The DrWell Provider Network is the premier path to success for weight loss and wellness practices
The FDA has sent several warning letters to GLP-1 compounders using salts, as well as companies selling drugs with non-FDA-approved peptide therapies retatrutide and cagrilintide for weight loss, over the last few years
Two years ago, Jennifer Kirtley looked down at the scale and saw 328 pounds
Last updated April 2026 Medically reviewed by Ana Reisdorf, MS, RD Sources verified against the Zepbound FDA prescribing information, NEJM SURMOUNT-1 (Jastreboff 2022), JAMA SURMOUNT-4 (Aronne 2023), and Lillys Zepbound consumer page
Matt Williams: Yeah, its just going to depend upon each persons level of risk that they want to take as long as they know the risks and are comfortable with the risks, if theyre comfortable with those risks, and if theyre small and they want to use the drugs for diabetes or weight loss, at least theyre making an informed decision